Skip to main content
Premium Trial:

Request an Annual Quote

Pittsburgh Business Backer Invests $150K in siRNA Chip Startup Falcon Genomics

NEW YORK (GenomeWeb News) - The Pittsburgh Life Sciences Greenhouse, a public-private partnership that corrals start-up investment capital for Pittsburgh-area life sciences businesses, said Tuesday it will fuel a fledgling siRNA-focused business with $150,000, and will dish out $200,000 between two other biotech companies.
 
PLSG has invested $150,000 in Falcon Genomics to support validation of the company's Cancer BioChip System, which PLSG said is "a high throughput assay system for individualized cancer target identification and validation using silencing RNA."
 
The biochip system will be used to determine which abnormal gene is responsible for uncontrolled cell division that causes tumors to grow, allowing therapies to connect specific silencing agents to certain cancers.
 
PLSG also invested $100,000 each in Celsense, which is developing imaging technology to monitor transplanted cells; and Glucose Sensing Technologies, which is developing a colorimetric sensor for glucose monitoring.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.